Profile

New User

New to Graphy Publications? Create an account to get started today.

Registered Users

Have an account? Sign in now.

How to Cite | Author Information | Publication History
International Journal of Clinical Pharmacology & Pharmacotherapy Volume 1 (2016), Article ID 1:IJCPP-104, 6 pages
https://doi.org/10.15344/2456-3501/2016/104
Research Article
Evaluation of Helicobacter pylori Eradication Therapy in Dyspeptic Patients in a Teaching Hospital

Ahmed A. Abusham 1* and Abdul Wahab H. Mohammed2

1School of Pharmacy, College of pharmacy and Nursing, University of Nizwa, Oman
2Sudan National Research Centre, Sudan
Dr. Ahmed A. Abusham, School of Pharmacy, College of pharmacy and Nursing, University of Nizwa, Birkat Al Mawz, Oman; E-mail: abusham@unizwa.edu.om
28 January 2016; 15 May 2016; 17 May 2016
Abusham AA, Mohammed AH (2016) Evaluation of Helicobacter pylori Eradication Therapy in Dyspeptic Patients in a Teaching Hospital. Int J Clin Pharmacol Pharmacother 1: 104. doi: https://doi.org/10.15344/2456-3501/2016/104
© 2016 Abusham et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

References

  1. Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311-1315 [CrossRef] [Google Scholar] [PubMed]
  2. Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology (2007) American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 102: 1808-1825 [CrossRef] [Google Scholar] [PubMed]
  3. Malfertheiner P, Mégraud F, O'Morain C, Hungin AP, Jones R, et al. (2002) Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16: 167- 180 [CrossRef] [Google Scholar] [PubMed]
  4. Amieva MR, El-Omar EM (2008) Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134: 306-323 [CrossRef] [Google Scholar] [PubMed]
  5. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, et al. (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56: 772-781 [CrossRef] [Google Scholar] [PubMed]
  6. Basso D, Zambon CF, Letley DP, Stranges A, Marchet A, et al. (2008) Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135: 91-99 [CrossRef] [Google Scholar] [PubMed]
  7. Tombola F, Morbiato L, Del Giudice G, Rappuoli R, Zoratti M, et al. (2001) The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia. J Clin Invest 108: 929-937 [CrossRef] [Google Scholar] [PubMed]
  8. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90 [CrossRef] [Google Scholar] [PubMed]
  9. Levi F, Lucchini F, Negri E, Zatonski W, Boyle P, et al. (2004) Trends in cancer mortality in the European Union and accession countries, 1980- 2000. Ann Oncol 15: 1425-1431 [CrossRef] [Google Scholar] [PubMed]
  10. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease (1994) NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 272: 65 [PubMed]
  11. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, et al. (2012) Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 61: 646-664 [CrossRef] [Google Scholar] [PubMed]
  12. Veldhuyzen van Zanten SJ, Sherman PM (1994) Indications for treatment of Helicobacter pylori infection: a systematic overview. CMAJ 150: 189-198 [Google Scholar] [PubMed]
  13. Fischbach LA, Goodman KJ, Feldman M, Aragaki C (2002) Sources of variation of Helicobacter pylori treatment success in adults worldwide: a meta-analysis. Int J Epidemiol 31: 128-139 [CrossRef] [Google Scholar] [PubMed]
  14. Peitz U, Menegatti M, Vaira D, Malfertheiner P (1998) The European meeting on Helicobacter pylori: therapeutic news from Lisbon. Gut 43 Suppl 1: S66-69 [CrossRef] [Google Scholar] [PubMed]
  15. Romano M, Cuomo A, Gravina AG, Miranda A, Iovene MR, et al. (2010) Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut 59: 1465-1470 [CrossRef] [Google Scholar] [PubMed]
  16. Zullo A, De Francesco V, Hassan C, Morini S, Vaira D (2007) The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 56: 1353-1357 [CrossRef] [Google Scholar] [PubMed]
  17. Song MJ, Park DI, Park JH, Kim HJ, Cho YK, et al. (2010) The effect of probiotics and mucoprotective agents on PPI-based triple therapy for eradication of Helicobacter pylori. Helicobacter 15: 206-213 [CrossRef] [Google Scholar] [PubMed]
  18. Vakil N (2005) Helicobacter pylori: factors affecting eradication and recurrence. Am J Gastroenterol 100: 2393-2394 [CrossRef] [Google Scholar] [PubMed]
  19. Mégraud F, Lehours P (2007) Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 20: 280-322 [CrossRef] [Google Scholar] [PubMed]
  20. Osato MS, Reddy R, Reddy SG, Penland RL, Malaty HM, et al. (2001) Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med 161: 1217-1220 [CrossRef] [Google Scholar] [PubMed]
  21. Bilardi C, Dulbecco P, Zentilin P, Reglioni S, Iiritano E, et al. (2004) A 10- day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial. Clin Gastroenterol Hepatol 2: 997-1002 [CrossRef] [Google Scholar] [PubMed]
  22. Chi CH, Lin CY, Sheu BS, Yang HB, Huang AH, et al. (2003) Quadruple therapy containing amoxicillin and tetracycline is an effective regimen to rescue failed triple therapy by overcoming the antimicrobial resistance of Helicobacter pylori. Aliment Pharmacol Ther 18: 347-353 [CrossRef] [Google Scholar] [PubMed]
  23. Liu H, Rahman A, Semino-Mora C, Doi SQ, Dubois A (2008) Specific and sensitive detection of H. pylori in biological specimens by real-time RT-PCR and in situ hybridization. PLoS One 3: e2689 [CrossRef] [Google Scholar] [PubMed]
  24. The British National Formulary (BNF) (2012) A joint publication of the British Medical Association and the Royal Pharmaceutical Society of Great Britain 63
  25. Chey WD, Wong BC; Practice Parameters Committee of the American College of Gastroenterology (2007) American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 102: 1808-1825 [CrossRef] [Google Scholar] [PubMed]
  26. Calvet X, Sánchez-Delgado J, Montserrat A, Lario S, Ramírez-Lázaro MJ, et al. (2009) Accuracy of diagnostic tests for Helicobacter pylori: a reappraisal. Clin Infect Dis 48: 1385-1391 [CrossRef] [Google Scholar] [PubMed]
  27. Gisbert JP, Esteban C, Jimenez I, Moreno-Otero R (2007) 13C-urea breath test during hospitalization for the diagnosis of Helicobacter pylori infection in peptic ulcer bleeding. Helicobacter 12: 231-237 [CrossRef] [Google Scholar] [PubMed]
  28. Lind T, Megraud F, Bardhan KD, (1997) The MACH2 study: antimicrobial resistance in Helicobacter pylori therapy: The impact of omeprazole. Gut 41: (suppl1): A89
  29. Vaira D, Zullo A, Vakil N, Gatta L, Ricci C, et al. (2007) Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann Intern Med 146: 556-563 [CrossRef] [Google Scholar] [PubMed]
  30. Huang JQ, Wilkinson JM, Chiba N (1997) One-week clarithromyein 500mg bid is better than 250 bid for eradicating H pylori infection when combined with proton pump inhibitor and metronidazole or amoxicillin: a metaanalysis [Abstract]. Gut 41(suppl1): A90
  31. Fischbach LA, van Zanten S, Dickason J (2004) Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther 20: 1071-1082 [CrossRef] [Google Scholar] [PubMed]
  32. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ Jr, et al. (1992) Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 102: 493-496 [CrossRef] [Google Scholar] [PubMed]
Best viewed in Mozilla Firefox, Google Chrome, Safari, Above IE 9.0 version
Privacy Policy | Copyright & Permissions
Copyright © 2013-2024 Graphy Publications, All Rights Reserved.